1. Home
  2. VTEX vs CADL Comparison

VTEX vs CADL Comparison

Compare VTEX & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VTEX

VTEX

VTEX

HOLD

Current Price

$3.61

Market Cap

649.6M

Sector

Technology

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.51

Market Cap

578.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTEX
CADL
Founded
1999
1999
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
649.6M
578.8M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
VTEX
CADL
Price
$3.61
$8.51
Analyst Decision
Buy
Strong Buy
Analyst Count
6
7
Target Price
$5.97
$19.00
AVG Volume (30 Days)
1.3M
2.0M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
N/A
$125,000.00
Revenue This Year
$12.78
N/A
Revenue Next Year
$9.63
N/A
P/E Ratio
$43.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.84
$4.35
52 Week High
$6.82
$9.57

Technical Indicators

Market Signals
Indicator
VTEX
CADL
Relative Strength Index (RSI) 46.26 56.76
Support Level $3.39 $4.80
Resistance Level $4.19 $9.42
Average True Range (ATR) 0.17 0.57
MACD -0.01 -0.09
Stochastic Oscillator 22.46 37.35

Price Performance

Historical Comparison
VTEX
CADL

About VTEX VTEX

Vtex provides a software-as-a-service digital commerce platform for enterprise brands and retailers. Its platform enables customers to execute their commerce plan, including building online stores, integrating and managing orders across channels, and creating marketplaces to sell products from third-party vendors. The VTEX platform is designed to be composable and complete, enabling its customers to seamlessly implement, optimize, test, and expand both B2C and B2B digital experiences. It generates maximum revenues from Brazil followed by Latin America and the rest of the world.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: